Zhaoping He

Assistant Research Professor

Thomas Jefferson University
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (2)

Objectives Functional dyspepsia (FD) is a disorder of the gut–brain interaction characterized by epigastric pain, nausea, and/or early satiety. Existing literature suggests a physical link between psychiatric diagnoses and disorders of the gut–brain interaction at intestinal mast cells (MC) via corticotropin‐releasing hormone (CRH) and its intestinally located receptors (CRHR1/CRHR2). Our study aimed to further clarify the physiologic connection between pediatric psychiatric illness and FD. Methods Study subjects were identified and classified into three groups. The FD group met Rome IV criteria and had insignificant gross endoscopic and histologic findings on gastric and duodenal biopsies. The control group reported no gastrointestinal symptoms or documented psychiatric illness. A third group consisted of Helicobacter pylor i (HP)‐positive dyspepsia patients independent of psychiatric history. Duodenal biopsy blocks were stained with antibodies targeting MCs, CRH, and CRHR1/CRHR2. Results We included 49 patients: 21 FD, nine controls, and 19 HP patients. We found a statistical difference between duodenal MC density in FD versus controls and HP versus controls ( p < 0.05). We found no significant CRHR2 staining in the control group, yet the FD and HP groups yielded strong stains. We found a significant increase in MC density and CRHR2 staining in patients with a psychiatric history versus without ( p < 0.05). Conclusion Our data show increased MC density and stronger CRHR2 staining in patients with FD and in patients with a psychiatric history. Our data support a pathophysiologic theory of FD development via a “gut–brain axis” intersecting at the level of MCs with influence via peripheral CRH.

Year:

2025

Objectives The incidence of eosinophilic esophagitis (EoE) is 3−5 times greater in patients with inflammatory bowel disease (IBD) compared with the general population. This study aimed to differentiate true EoE from esophageal eosinophilia in IBD patients by evaluating expression of major basic protein (MBP) and interleukin‐13 (IL‐13) in esophageal biopsies. Methods This retrospective study included subjects who had an esophagogastroduodenoscopy with esophageal biopsies for IBD work up or suspicion for EoE. Patients were classified into 5 groups: EoE with ≥15 eosinophils per high power field (eos/hpf), EoE‐IBD with ≥15 eos/hpf, IBD eosinophilia with 1−14 eos/hpf, IBD and control groups. Biopsies were stained with MBP and IL‐13 antibodies and the results (% staining/total tissue area), demographic, and clinical findings were compared among the groups. Results The median for MBP staining levels in EoE‐IBD was 3.8 (interquartile range 1.3−23), significantly lower than in EoE at 52.8 (8.3−113.2), but higher than in IBD eosinophilia at 0.2 (0−0.9; p < 0.001) and negligible in the IBD and control groups. IL‐13 expression in EoE was significantly higher only compared with IBD and controls not with EoE‐IBD or IBD eosinophilia. MBP predicted EoE with 100% sensitivity and 99% specificity while IL‐13 had 83% sensitivity and 90% specificity using cutoff point from the cohort without EoE‐IBD patients. Based on MBP cutoff point that distinguished EoE from non EoE, 56% in EoE‐IBD were MBP‐positive whereas 100% in EoE group ( p < 0.05). Conclusions MBP may be an excellent marker in distinguishing true EoE from eosinophilia caused by IBD. Our data implied that MBP together with endoscopic and histologic changes can assist EoE diagnosis in IBD patients.

Year:

2024

Collaborators (1)

Timothy Chao

Assistant Professor

University of Pennsylvania

UNITED STATES
View details